Skip to content

The Effect of Foot Massage with Juglans regia Oil on Neuropathy Symptoms and Severity of Pain in Patients with Diabetic Neuropathy

The Effect of Foot Massage with Juglans regia Oil on Neuropathy Symptoms and Severity of Pain in Patients with Diabetic Neuropathy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250617066205N1
Enrollment
87
Registered
2025-07-21
Start date
2025-07-30
Completion date
Unknown
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathy.

Interventions

Intervention 1: Intervention group: Foot massage with Juglans regia oil will be performed by the patient using the effleurage technique. Each foot will be massaged for ten minutes, three times a week

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged between 40 and 65 years Diagnosed with type 2 diabetes for at least 3 years Ability to communicate verbally and consciously Presence of neuropathy with a score of 7 or higher on the Michigan Neuropathy Screening Instrument (MNSI) Presence of neuropathic pain with a minimum score of 4 on the DN4 Neuropathic Pain Questionnaire Providing informed consent to participate in the study No addiction to drugs or alcohol Patient’s ability to independently perform the intervention Not participating in other interventional studies during the study period No foot massage with herbal oils in the past two months No diagnosed neurological disorders such as Parkinson’s disease, brain tumors, psychiatric disorders, autism, meningitis, Alzheimer’s disease, or multiple sclerosis, based on patient self-report No allergy to Juglans regia Oil No open wounds, active infections, eczema, or other serious skin conditions on the feet or hands that may interfere with foot massage No history of foot surgery in the past year

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Neuropathy severity. Timepoint: At the beginning of the study and four weeks afterward. Method of measurement: Michigan Diabetic Neuropathy Score (MDNS).;Pain severity. Timepoint: At the beginning of the study and four weeks afterward. Method of measurement: Douleur Neuropathique 4 Questions (DN4) questionnaire.

Secondary

MeasureTime frame
Sleep quality. Timepoint: At the beginning of the study and four weeks afterward. Method of measurement: Pittsburgh Sleep Quality Index (PSQI).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Rezaei Shahsavarloo

Kashan University of Medical Sciences

zahrarezaie23@yahoo.com+98 31 5510 3145

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026